Multiplex Assays Market Research Report – Forecast to 2027

Global Multiplex Assays Market: By Products and Services (Consumables, Instruments), by Types (Protein & Nucleic Acid Assay), by Technology (Flow Cytometry & Other Technology), by Application (Clinical Diagnostic), & End-User (Hospital)– Forecast Till 2027

ID: MRFR/HC/4677-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global multiplex assays market is expected to reach an approximate CAGR of 7.8% during the forecast period. An assay which simultaneously measures multiple analysts in a single cycle is known as a multiplex assay. Technological advancement is one of the driving factors for the growth of this market. The rapid development in nanotechnology has taken this to the next level of nanoarray, which represents the ultra-miniaturization version of the conventional microarray. Increasing awareness about the multifactorial nature of various diseases and pathological conditions such as cancer and Alzheimer disease has created a requirement to produce a cost-effective and time-saving measurement of multiple analysts in a single sample. This factor drives the global multiplex assays market.


Reproducibility crisis and complex clinical trial procedures for multiplex assay products are limiting the growth of the market.


Segmentation


The global multiplex assays market is segmented on the basis of products and services, types, technology, application, and end-user. On the basis of products and services, the multiplex assays market is segmented into consumable, instrument, and software and services. Based on types, the market is segmented into protein, nucleic acid, and cell-based multiplex assay. Further, protein multiplex assay is sub-segmented into planer protein assay and bead-based protein assay. Nucleic acid multiplex assay is further sub-segmented into planer nucleic acid assay, bead-based nucleic acid assay, and other nucleic acid assay. On the basis of technology, the multiplex assay market is further segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies. Further on the basis of application, the market is segmented into research and development, clinical diagnostic, and other diseases. Research and development is further sub-segmented into drug discovery and development, biomarker discovery, and validation. Clinical diagnostic is further sub-segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and other diseases. Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, hospital and research institutes, clinical laboratories, and other end-users.


Key players


Some of the key players in the global multiplex assays market are Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD, Merck Sharp & Dohme Corp, Agilent Technologies, Meso Scale Diagnostics LLC, Randox Laboratories Ltd,  Quanterix, Bio-Techne, and  Seegene Inc.


Regional Market Summary


Global Multiplex Assays Market Share (%), by Region, 2018


Multiplex Assay  Market Share


Sources: National Electronic Health Records Survey, U.S. Department of Health & Human Services, National Centre for Health Statistics


The multiplex assays market is divided into four major regions, namely, North America, Europe, Asia-Pacific, and the rest of the world. North America accounts for the largest share of the multiplex assays market owing to strong R&D activities in this region. The US is a leading country in biopharmaceutical research and development. The key factors that drive the growth of the market in this region are increase in patient population, the rise in the prevalence of Alzheimer disease, and a significant rise in research and development activities in pharmaceutical companies for the treatment of diseases such as cancer and Alzheimer.  


Asia-Pacific is expected to register the highest CAGR during the forecast period. Factors influencing the growth of this region include increasing geriatric population, rising prevalence of cataract, and increasing prevalence of Alzheimer disease in this region.


The European region is projected to register the highest CAGR during the forecast period due to increasing geriatric population included in system illness and chronic infection.


The Middle East and Africa holds the least share in the global multiplex assay market due to the presence of stringent government policies and poor economies.


Market Segmentation and Key Market Players


Global Multiplex Assays Market, by Products & Services



  • Consumable

  • Instrument

  • Software & Services


Global Multiplex Assays market, by Type



  • Protein multiplex assay

  • Planer protein assay

  • Bead-based protein assay

  • Nucleic acid multiplex assay

  • Planer nucleic acid assay

  • Bead-based nucleic acid assay

  • Other nucleic acid assay

  • Cell-based multiplex assay


Global Multiplex Assays Market, by Technology



  • Flow cytometry

  • Fluorescence detection

  • Luminescence

  • Multiplex real-time PCR

  • Other technology


Global Multiplex Assays Market, by Application



  • Research & development

  • Drug discovery & development

  • Biomarker discovery & validation

  • Clinical diagnostic

  • Infectious disease

  • Cancer

  • Cardiovascular disease

  • Autoimmune disease

  • Nervous system disorders

  • Other diseases


Global Multiplex Assays Market, by End-User



  • Pharmaceutical and biotechnology companies

  • Hospitals

  • Research institutes

  • Clinical laboratories

  • Other end-users


Global Multiplex Assays Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Global Multiplex Assays Market, by Key Players



  • Thermo Fisher Scientific Inc

  • Illumina Inc

  • Bio-Rad Laboratories Inc

  • Qiagen

  • Abcam plc

  • BD

  • Merck Sharp & Dohme Corp

  • Agilent Technologies

  • Meso Scale Diagnostics LLC

  • Randox Laboratories Ltd

  • Quanterix,

  • Bio-Techne

  • Seegene Inc.


Intended Audience



  • Biotechnology company

  • Pharmaceutical company

  • Government & private laboratories

  • Research & development companies

  • Medical research laboratories



Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Multiplex Assay Market, by Products & Services

6.1 Introduction

6.2 Consumable

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Instrument

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Software & Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Multiplex Assay Market, by Types

7.1 Introduction

7.2 Protein Multiplex Assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1 Planer protein assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2 Bead-based protein assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Nucleic Acid Multiplex Assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.1 Planer nucleic acid assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Bead-based nucleic acid assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Other nucleic acid assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Cell-based multiplex assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Multiplex Assay Market, by Application

8.1 Introduction

8.2 Research & development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.1 Drug discovery & development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.2 Biomarker discovery & validation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Clinical diagnostic

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.1 Infectious disease

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.2 Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.3 Cardiovascular disease

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.4 Autoimmune disease

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.5 Nervous system disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Multiplex Assay Market, by End-User

9.1 Pharmaceutical and biotechnology companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.2 Hospital & Research Institute

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Clinical laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Other End-User

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Multiplex Assay Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Thermo Fisher Scientific Inc

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Illumina Inc

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bio Rad Laboratories Inc

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Qiagen

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Abcam plc

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 BD

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Merck Sharp & Dohme Corp

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Agilent Technologies

12.8.1 Overview

12.8.2 Product/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Meso Scale Diagnostics LLC

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Randox Laboratories Ltd

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12. 11 Quanterix

12. 11.1 Overview

12. 11.2 Product Overview

12. 11.3 Financials

12. 11.4 Key Developments

12. 11.5 SWOT Analysis

12.12 Bio-Techne

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Seegene Inc

13.13.1 Overview

13.13.2 Product Overview

13.13.3 Financials

13.13.4 Key Developments

13.13.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Multiplex Assay Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Multiplex Assay Market Synopsis, 2020-2027

Table 2 Global Multiplex Assay Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Multiplex Assay Market, by Region, 2020-2027 (USD Million)

Table 4 Global Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

Table 5 Global Multiplex Assay Market, by Types, 2020-2027 (USD Million

Table 6 Global Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

Table 7 Global Multiplex Assay Market, by Application, 2020-2027 (USD Million)

Table 8 North America: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

Million)

Table 9 North America: Multiplex Assay Market, by Types, 2020-2027 (USD

Million)

Table 10 North America: Multiplex Assay Market, by End-User, 2020-2027 (USD

Million)

Table 11 North America: Multiplex Assay Market, by Application, 2020-2027 (USD

Million)

Table 12 US: Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

Table 13 US: Multiplex Assay Market, by Types, 2020-2027 (USD Million)

Table 14 US: Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

Table 15 US: Multiplex Assay Market, by Application, 2020-2027 (USD Million)

Table 16 Canada: Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

Table 17 Canada: Multiplex Assay Market, by Types, 2020-2027 (USD Million)

Table 18 Canada: Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

Table 19 Canada: Multiplex Assay Market, by Application, 2020-2027 (USD

Million)

Table 20 South America: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

Million)

Table 21 South America: Multiplex Assay Market, by Types, 2020-2027 (USD

Million)

Table 22 South America: Multiplex Assay Market, by End-User, 2020-2027 (USD

Million)

Table 23 South America: Multiplex Assay Market, by Application, 2020-2027 (USD

Million)

Table 24 Europe: Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

Table 25 Europe: Multiplex Assay Market, by Types, 2020-2027 (USD Million)

Table 26 Europe: Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

Table 27 Europe: Multiplex Assay Market, by Application, 2020-2027 (USD Million)

Table 28 Western Europe: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

Million)

Table 29 Western Europe: Multiplex Assay Market, by Types, 2020-2027 (USD

Million)

Table 30 Western Europe: Multiplex Assay Market, by End-User, 2020-2027 (USD

Million)

Table 31 Western Europe: Multiplex Assay Market, by Application, 2020-2027

(USD Million)

Table 32 Eastern Europe: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

Million)

Table 33 Eastern Europe: Multiplex Assay Market, by Types, 2020-2027 (USD

Million)

Table 34 Eastern Europe: Multiplex Assay Market, by End-User, 2020-2027 (USD

Million)

Table 35 Eastern Europe: Multiplex Assay Market, by Application, 2020-2027

(USD Million)

Table 36 Asia-Pacific: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

Million)

Table 37 Asia-Pacific: Multiplex Assay Market, by Types, 2020-2027 (USD

Million)

Table 38 Asia-Pacific: Multiplex Assay Market, by End-User, 2020-2027 (USD

Million)

Table 39 Asia-Pacific: Multiplex Assay Market, by Application, 2020-2027 (USD

Million)

Table 40 Middle East & Africa: Multiplex Assay Market, by Products & Services, 2020-2027

(USD Million)

Table 41 Middle East & Africa: Multiplex Assay Market, by Types, 2020-2027

(USD Million)

Table 42 Middle East & Africa: Multiplex Assay Market, by End-User, 2020-2027

(USD Million)

Table 43 Middle East & Africa: Multiplex Assay Market, by Application, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Multiplex Assay Market

Figure 3 Segmentation Market Dynamics for Global Multiplex Assay Market

Figure 4 Global Multiplex Assay Market Share, by Products & Services, 2020

Figure 4 Global Multiplex Assay Market Share, by Types, 2020

Figure 5 Global Multiplex Assay Market Share, by End-User, 2020

Figure 6 Global Multiplex Assay Market Share, by Application, 2020

Figure 7 Global Multiplex Assay Market Share, by Region, 2020

Figure 8 North America: Multiplex Assay Market Share, by Country, 2020

Figure 9 Europe: Multiplex Assay Market Share, by Country, 2020

Figure 10 Asia-Pacific: Multiplex Assay Market Share, by Country, 2020

Figure 11 Middle East & Africa: Multiplex Assay Market Share, by Country, 2020

Figure 12 Global Multiplex Assay Market: Company Share Analysis, 2020 (%)

Figure 13 Thermo Fisher Scientific Inc.: Key Financials

Figure 14 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 15 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 16 Illumina Inc.: Key Financials

Figure 17 Illumina Inc.: Segmental Revenue

Figure 18 Illumina Inc.: Geographical Revenue

Figure 19 Bio Rad Laboratories Inc: Key Financials

Figure 20 Bio Rad Laboratories Inc.: Segmental Revenue

Figure 21 Bio Rad Laboratories Inc.: Geographical Revenue

Figure 22 Qiagen: Key Financials

Figure 23 Qiagen: Segmental Revenue

Figure 24 Qiagen: Geographical Revenue

Figure 25 Abcam plc: Key Financials

Figure 26 Abcam plc: Segmental Revenue

Figure 27 Abcam plc: Geographical Revenue

Figure 28 BD: Key Financials

Figure 29 BD: Segmental Revenue

Figure 30 BD: Geographical Revenue

Figure 31 Merck Sharp & Dohme Corp: Key Financials

Figure 32 Merck Sharp & Dohme Corp: Segmental Revenue

Figure 33 Merck Sharp & Dohme Corp: Geographical Revenue

Figure 34 Agilent Technologies: Key Financials

Figure 35 Agilent Technologies: Segmental Revenue

Figure 36 Agilent Technologies: Geographical Revenue

Figure 37 Meso Scale Diagnostics LLC: Key Financials

Figure 38 Meso Scale Diagnostics LLC: Segmental Revenue

Figure 39 Meso Scale Diagnostics LLC: Geographical Revenue

Figure 40 Randox Laboratories Ltd: Key Financials

Figure 41 Randox Laboratories Ltd: Segmental Revenue

Figure 42 Randox Laboratories Ltd: Geographical Revenue

Figure 43 Quanterix: Key Financials

Figure 44 Quanterix: Segmental Revenue

Figure 45 Quanterix: Geographical Revenue

Figure 46 Bio-Techne: Key Financials

Figure 47 Bio-Techne: Segmental Revenue

Figure 48 Bio-Techne: Geographical Revenue

Figure 49 Seegene Inc: Key Financials

Figure 50 Seegene Inc: Segmental Revenue

Figure 51 Seegene Inc: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.